-+*Meredith Greene, Associate Director, Geriatric HIV Consultation Clinic, Zuckerberg San Francisco General Hospital, San Francisco Meredith Greene : Loneliness in Older Adults Living with HIV More than half of people living with HIV in Canada and the US are now over 50 years old. As they age, more are reporting experiencing loneliness. What impact does […]
Meredith Greene : Loneliness in Older Adults Living with HIV Read More »
-+*Ian Green, Chief Executive, Terrence Higgins Trust, UK Innovations in Testing How can we reach the 14% of Ontarians—just over 3,000 people—who have HIV but have not yet been diagnosed? This plenary talks about innovative ways to make HIV testing more accessible to more people. What’s the potential to bring these innovations to Ontario? What
Ian Green : HIV self-testing in the UK Read More »
-+*Deborah Kelly, Memorial University Innovations In Testing How can we reach the 14% of Ontarians—just over 3,000 people—who have HIV but have not yet been diagnosed? This plenary talks about innovative ways to make HIV testing more accessible to more people. What’s the potential to bring these innovations to Ontario? What else should we be
Deborah Kelly : HIV testing at the Pharmacy : The APPROACH Study Read More »
-+*Daniel Grace, Dalla Lana School of Public Health, University of Toronto Innovations In Testing How can we reach the 14% of Ontarians—just over 3,000 people—who have HIV but have not yet been diagnosed? This plenary talks about innovative ways to make HIV testing more accessible to more people. What’s the potential to bring these innovations
-+*Roy Gulick, Professor of Medicine and Chief of the Division of Infectious Diseases, Weill Medical College, Cornell University The Future of Antiretroviral Therapy ART regimens have improved significantly over the years. What’s next? Will new regimens and new delivery mechanisms improve care and adherence? Descriptive Transcript Thanks a lot Sharon. Thanks to Jean and the
Roy Gulick : The Future of Antiretroviral Therapy Read More »
-+*Michael Brady, Medical Director, Terrence Higgins Trust, UK Talking U=U “Undetectable = Untransmissible” is one of the most positive messages people living with HIV can hear. It reduces the stigma associated with HIV and provides motivation to stay on treatment to keep both themselves and their sexual partners healthy. Yet many clinicians still struggle with
Dr Michael Brady : Talking U=U : Can’t Pass It On Read More »
-+*Andrew Grulich, Professor and Program Head HIV Epidemiology and Prevention Program, Kirby Institute, UNSW Sydney, Australia Targeted Rapid PrEP: Impact & Lessons Learned New South Wales was the first state in Australia to trial PrEP at a large scale. The high-level, targeted, rapid roll-out of PrEP led to a 25% decline in state-wide HIV diagnoses
Andrew Grulich : Targeted rapid PrEP : Impact & Lessons Learned Read More »
-+*Abigail Kroch, of The OHTN, opens the HIV Endgame 3: Breakthrough Initiatives conference, sets the stage for the two-day conference, and highlights key HIV epidemiology data in Ontario. Descriptive Transcript The HIV Endgame logo appears on screen. Text reads: Setting the Stage HIV in Ontario. Abigail Kroch, PhD M.P.H. Director of Data and Applied Science
Abigail Kroch : HIV Endgame 3: Setting the Stage | HIV in Ontario Read More »
